These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32064287)

  • 21. FDG PET imaging in sarcoidosis.
    Sobic-Saranovic D; Artiko V; Obradovic V
    Semin Nucl Med; 2013 Nov; 43(6):404-11. PubMed ID: 24094707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac and Pericardial
    Yi JE; Yoon HJ; O JH; Youn HJ
    J Cardiovasc Imaging; 2018 Jun; 26(2):93-102. PubMed ID: 29971271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
    Huber H; Hodolic M; Stelzmüller I; Wunn R; Hatzl M; Fellner F; Lamprecht B; Rubello D; Colletti PM; Gabriel M
    Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcoidosis with bone involvement mimicking metastatic disease at (18)F-FDG PET/CT: problem solving by diffusion whole-body MRI.
    Conte G; Zugni F; Colleoni M; Renne G; Bellomi M; Petralia G
    Ecancermedicalscience; 2015; 9():537. PubMed ID: 26015806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.
    Akaike G; Itani M; Shah H; Ahuja J; Yilmaz Gunes B; Assaker R; Behnia F
    Radiographics; 2018; 38(5):1536-1549. PubMed ID: 30118393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis.
    Nelson DR; Johnson GB; Cartin-Ceba R; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):342-52. PubMed ID: 26847102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
    Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
    Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
    Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
    Imperiale A; Riehm S; Braun JJ
    Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):177-86. PubMed ID: 23598684
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Prakash G; Singh N
    AJR Am J Roentgenol; 2019 Jan; 212(1):W10-W18. PubMed ID: 30383406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.
    Shejul Y; Chhajed PN; Basu S
    J Nucl Med Technol; 2014 Sep; 42(3):235-7. PubMed ID: 24948823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular imaging in sarcoidosis.
    Mañá J; Gámez C
    Curr Opin Pulm Med; 2011 Sep; 17(5):325-31. PubMed ID: 21597377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
    Lu Y; Sweiss NJ
    Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sub-Acute Thyroiditis presenting as pyrexia of unknown origin: A rare case with literature review.
    Mukhtar R
    J Pak Med Assoc; 2022 Mar; 72(3):560-563. PubMed ID: 35320246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
    Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
    Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Utility of
    Chen H; Jin R; Wang Y; Li L; Li K; He Y
    Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive FDG PET CT Scan in Vertebral Hemangioma.
    Solav SV; Savale SV; Patil AM
    Asia Ocean J Nucl Med Biol; 2019; 7(1):95-98. PubMed ID: 30705916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET imaging in HIV infection and tuberculosis.
    Sathekge M; Maes A; Van de Wiele C
    Semin Nucl Med; 2013 Sep; 43(5):349-66. PubMed ID: 23905617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.